LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,460 | 2 | 19,660 | 15,891 | 18,151 |
| Depreciation Amortization | 910 | 456 | 1,881 | 1,417 | 949 |
| Accounts receivable | 2,683 | 2,881 | -2,776 | -2,959 | -2,762 |
| Accounts payable and accrued liabilities | -153 | 511 | -484 | -448 | -920 |
| Other Working Capital | 2,821 | 2,187 | -5,031 | -2,375 | -1,864 |
| Other Operating Activity | 482 | -3,516 | 14,994 | 13,554 | 10,760 |
| Operating Cash Flow | $9,203 | $2,521 | $28,244 | $25,080 | $24,314 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 271 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | N/A | -9 | -9 | N/A |
| Investing Cash Flow | $271 | $N/A | $-9 | $-9 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 260 | 159 | 592 | 473 | 353 |
| Common Stock Repurchased | -8,064 | -5,179 | -3,380 | N/A | 0 |
| Financing Cash Flow | $-7,804 | $-5,020 | $-2,788 | $473 | $353 |
| Beginning Cash Position | 46,708 | 46,708 | 21,261 | 21,261 | 21,261 |
| End Cash Position | 48,378 | 44,209 | 46,708 | 46,805 | 45,928 |
| Net Cash Flow | $1,670 | $-2,499 | $25,447 | $25,544 | $24,667 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,203 | 2,521 | 28,244 | 25,080 | 24,314 |
| Capital Expenditure | N/A | N/A | -9 | -9 | N/A |
| Free Cash Flow | 9,203 | 2,521 | 28,235 | 25,071 | 24,314 |